Literature DB >> 33097969

Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review.

Nuno G Oliveira1, Daniela L Ramos2,3, Ricardo Jorge Dinis-Oliveira4,5,6.   

Abstract

Areca nut (AN) is consumed by more than 600 million of individuals, particularly in some regions of South Asia, East Africa, and tropical Pacific, being classified as carcinogenic to humans. The most popular way of exposure consists of chewing a mixture of AN with betel leaf, slaked lime, and other ingredients that may also contain tobacco named betel quid (BQ). Arecoline is the principal active compound of AN, and, therefore, has been systematically studied over the years in several in vitro and in vivo genotoxicity endpoints. However, much of this information is dispersed, justifying the interest of an updated and comprehensive review article on this topic. In this sense, it is thus pertinent to describe and integrate the genetic toxicology data available as well as to address key toxicokinetics aspects of arecoline. This review also provides information on the effects induced by arecoline metabolites and related compounds, including other major AN alkaloids and nitrosation derivatives. The complexity of the chemicals involved renders this issue a challenge in genetic toxicology. Overall, positive results in several endpoints have been reported, some of them suggesting a key role for arecoline metabolites. Nevertheless, some negative genotoxicity findings for this alkaloid in short-term assays have also been reported in the literature. Finally, this article also collates information on the potential mechanisms of arecoline-induced genotoxicity, and suggests further approaches to tackle this important toxicological issue.

Entities:  

Keywords:  Areca nut; Arecoline; Cancer; Genotoxicity; Toxicokinetics

Year:  2020        PMID: 33097969     DOI: 10.1007/s00204-020-02926-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  101 in total

1.  Betel chewing in retrospect.

Authors:  B G Burton-Bradley
Journal:  P N G Med J       Date:  1978-09

2.  Areca nut dependence among chewers in a South Indian community who do not also use tobacco.

Authors:  Shrihari J S Bhat; Melissa D Blank; Robert L Balster; Mimi Nichter; Mark Nichter
Journal:  Addiction       Date:  2010-07       Impact factor: 6.526

Review 3.  Areca nut trade, globalisation and its health impact: perspectives from India and South-east Asia.

Authors:  Shelly Arora; Christopher Squier
Journal:  Perspect Public Health       Date:  2018-06-29

4.  Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.

Authors:  S Asthana; N H Greig; H W Holloway; K C Raffaele; A Berardi; M B Schapiro; S I Rapoport; T T Soncrant
Journal:  Clin Pharmacol Ther       Date:  1996-09       Impact factor: 6.875

Review 5.  Human flavin-containing monooxygenases.

Authors:  John R Cashman; Jun Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

6.  Aqueous extract of betel nut-induced adducts on pMTa4 DNA acquires stability in the presence of Na+ and K+ ions.

Authors:  Chaitali Bhattacharjee; Rajeshwar Nath Sharan
Journal:  Mol Med Rep       Date:  2008 May-Jun       Impact factor: 2.952

7.  Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro.

Authors:  Y C Chang; K W Tai; M H Cheng; L S Chou; M Y Chou
Journal:  J Oral Pathol Med       Date:  1998-02       Impact factor: 4.253

8.  Associations between betel nut (Areca catechu) and symptoms of schizophrenia among patients in Nepal: A longitudinal study.

Authors:  Alicia Bales; Michael J Peterson; Saroj Ojha; Kapil Upadhaya; Baikunta Adhikari; Bruce Barrett
Journal:  Psychiatry Res       Date:  2009-09-11       Impact factor: 3.222

9.  Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: a pharmacogenetic approach.

Authors:  M Al-Waiz; R Ayesh; S C Mitchell; J R Idle; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1987-12       Impact factor: 6.875

10.  Mercapturic acid formation during the metabolism of arecoline and arecaidine in the rat.

Authors:  E Boyland; R Nery
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

View more
  8 in total

1.  A cocktail of carcinogens from betel quid chewing.

Authors:  Sachin C Sarode; Gargi S Sarode
Journal:  Arch Toxicol       Date:  2021-04-25       Impact factor: 5.153

Review 2.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

3.  Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway.

Authors:  Hai Xie; Ren Jing; Xiaoting Liao; Haishao Chen; Xianlong Xie; Huijun Dai; Linghui Pan
Journal:  Hereditas       Date:  2022-07-14       Impact factor: 2.595

4.  Improvement of autophagic flux mediates the protection of hydrogen sulfide against arecoline-elicited neurotoxicity in PC12 cells.

Authors:  Sheng-Lan Gao; Yi-Yun Tang; Jia-Mei Jiang; Wei Zou; Ping Zhang; Xiao-Qing Tang
Journal:  Cell Cycle       Date:  2022-03-22       Impact factor: 5.173

5.  Comment on "Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review".

Authors:  Sachin C Sarode; Gargi S Sarode
Journal:  Arch Toxicol       Date:  2021-03-18       Impact factor: 5.153

6.  Betel Nut Chewing Is Associated with the Risk of Kidney Stone Disease.

Authors:  Chun-Kai Chang; Jia-In Lee; Chu-Fen Chang; Yung-Chin Lee; Jhen-Hao Jhan; Hsun-Shuan Wang; Jung-Tsung Shen; Yao-Hsuan Tsao; Shu-Pin Huang; Jiun-Hung Geng
Journal:  J Pers Med       Date:  2022-01-18

7.  Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.

Authors:  Jinfei Li; Shuangyi Chen; Yuxuan Liao; Hongyi Wang; Dawei Zhou; Bo Zhang
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

8.  N-acetyl cysteine prevents arecoline-inhibited C2C12 myoblast differentiation through ERK1/2 phosphorylation.

Authors:  Yi-Xuan Li; Chun-Hung Hsiao; Yung-Fu Chang
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.